Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Does combined hormone replacement therapy improve the health-related quality of life of postmenopausal women?
Nachtigall L. Nachtigall L. Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):136-7. doi: 10.1038/ncpendmet1079. Nat Clin Pract Endocrinol Metab. 2009. PMID: 19229231
Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
Nachtigall MJ, Smilen SW, Nachtigall RD, Nachtigall RH, Nachtigall LE. Nachtigall MJ, et al. Among authors: nachtigall rd, nachtigall rh, nachtigall le. Obstet Gynecol. 1992 Nov;80(5):827-30. Obstet Gynecol. 1992. PMID: 1328978 Clinical Trial.
The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F. Gurney EP, et al. J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. J Steroid Biochem Mol Biol. 2014. PMID: 24172877 Review.
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women.
Nachtigall MJ, Jessel RH, Flaumenhaft R, Nachtigall R, Yoles I, Naftolin F, Nachtigall LE. Nachtigall MJ, et al. Menopause. 2011 Mar;18(3):285-8. doi: 10.1097/gme.0b013e3181f2f01a. Menopause. 2011. PMID: 21037489
Therapy: nonhormonal treatment of hot flashes-a viable alternative?
Nachtigall LE. Nachtigall LE. Nat Rev Endocrinol. 2010 Feb;6(2):66-7. doi: 10.1038/nrendo.2009.269. Nat Rev Endocrinol. 2010. PMID: 20098445
Menopausal changes, quality of life, and hormone therapy.
Nachtigall LE, Nachtigall MJ. Nachtigall LE, et al. Clin Obstet Gynecol. 2004 Jun;47(2):485-8. doi: 10.1097/00003081-200406000-00023. Clin Obstet Gynecol. 2004. PMID: 15166873 Review. No abstract available.
The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
Naftolin F, Taylor HS, Karas R, Brinton E, Newman I, Clarkson TB, Mendelsohn M, Lobo RA, Judelson DR, Nachtigall LE, Heward CB, Hecht H, Jaff MR, Harman SM; Women's Health Initiative. Naftolin F, et al. Fertil Steril. 2004 Jun;81(6):1498-501. doi: 10.1016/j.fertnstert.2004.02.095. Fertil Steril. 2004. PMID: 15193467
Effect of raloxifene on sexual function in postmenopausal women.
Kessel B, Nachtigall L, Plouffe L, Siddhanti S, Rosen A, Parsons A. Kessel B, et al. Among authors: nachtigall l. Climacteric. 2003 Sep;6(3):248-56. Climacteric. 2003. PMID: 14567773 Clinical Trial.
Lipid changes after hormone replacement therapy for menopause.
Kable WT, Gallagher JC, Nachtigall L, Goldgar D. Kable WT, et al. Among authors: nachtigall l. J Reprod Med. 1990 May;35(5):512-8. J Reprod Med. 1990. PMID: 2112606
Current attitudes on self-use and prescription of hormone therapy among New York City gynaecologists.
Devi G, Sugiguchi F, Pedersen AT, Abrassart D, Glodowski M, Nachtigall L. Devi G, et al. Among authors: nachtigall l. Menopause Int. 2013 Sep;19(3):121-6. doi: 10.1177/1754045313478941. Epub 2013 May 21. Menopause Int. 2013. PMID: 23761315
121 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback